Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Zhen

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 29, 2019
RETRACTED: Astragaloside IV protects cardiomyocytes from hypoxia-induced injury by down-regulation of lncRNA GAS5Jian Du, Jia Liu, Juan Zhen, et al.
Journal of Medicinal Chemistry|December 30, 2009
Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal modelsBalaram Ghosh, Tamara Antonio, Juan Zhen, et al.
Current Opinion in Structural Biology|August 27, 2010
Substrate and drug binding sites in LeuTAjeeta Nyola, Nathan K Karpowich, Juan Zhen, et al.
Journal of Neurochemistry|January 13, 2015
Dopamine transporter oligomerization: impact of combining protomers with differential cocaine analog binding affinitiesJuan Zhen, Tamara Antonio, Shu-Yuan Cheng, et al.
Acta Pharmacologica Sinica|April 15, 2020
Zinc as a countermeasure for cadmium toxicityHai-Tao Yu, Juan Zhen, Ji-Yan Leng, et al.
Journal of Neuroscience Methods|April 4, 2015
Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: comparison with functional GTPγS assaysJuan Zhen, Tamara Antonio, Solav Ali, et al.
Clinical Science (London, England : 1979)|June 14, 2018
PCSK9 in cholesterol metabolism: from bench to bedsideAllison B Reiss, Neal Shah, Dalia Muhieddine, et al.
Journal of Neurochemistry|December 16, 2016
Effects of diet and insulin on dopamine transporter activity and expression in rat caudate-putamen, nucleus accumbens, and midbrainKymry T Jones, Catherine Woods, Juan Zhen, et al.
Biochemical Pharmacology|September 14, 2010
Interaction of novel hybrid compounds with the D3 dopamine receptor: Site-directed mutagenesis and homology modeling studiesSandhya Kortagere, Shu-Yuan Cheng, Tamara Antonio, et al.
Journal of Medicinal Chemistry|July 11, 2006
Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transportersShijun Zhang, Fernando Fernandez, Stuart Hazeldine, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 29, 2019
RETRACTED: Astragaloside IV protects cardiomyocytes from hypoxia-induced injury by down-regulation of lncRNA GAS5Jian Du, Jia Liu, Juan Zhen, et al.
Journal of Medicinal Chemistry|December 30, 2009
Development of (S)-N6-(2-(4-(isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and its analogue as a D3 receptor preferring agonist: potent in vivo activity in Parkinson's disease animal modelsBalaram Ghosh, Tamara Antonio, Juan Zhen, et al.
Current Opinion in Structural Biology|August 27, 2010
Substrate and drug binding sites in LeuTAjeeta Nyola, Nathan K Karpowich, Juan Zhen, et al.
Journal of Neurochemistry|January 13, 2015
Dopamine transporter oligomerization: impact of combining protomers with differential cocaine analog binding affinitiesJuan Zhen, Tamara Antonio, Shu-Yuan Cheng, et al.
Acta Pharmacologica Sinica|April 15, 2020
Zinc as a countermeasure for cadmium toxicityHai-Tao Yu, Juan Zhen, Ji-Yan Leng, et al.
Journal of Neuroscience Methods|April 4, 2015
Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: comparison with functional GTPγS assaysJuan Zhen, Tamara Antonio, Solav Ali, et al.
Clinical Science (London, England : 1979)|June 14, 2018
PCSK9 in cholesterol metabolism: from bench to bedsideAllison B Reiss, Neal Shah, Dalia Muhieddine, et al.
Journal of Neurochemistry|December 16, 2016
Effects of diet and insulin on dopamine transporter activity and expression in rat caudate-putamen, nucleus accumbens, and midbrainKymry T Jones, Catherine Woods, Juan Zhen, et al.
Biochemical Pharmacology|September 14, 2010
Interaction of novel hybrid compounds with the D3 dopamine receptor: Site-directed mutagenesis and homology modeling studiesSandhya Kortagere, Shu-Yuan Cheng, Tamara Antonio, et al.
Journal of Medicinal Chemistry|July 11, 2006
Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transportersShijun Zhang, Fernando Fernandez, Stuart Hazeldine, et al.
Pageof 7